Merck Inventory Jumps; Keytruda Drives Q3 Revenue Beat, Forecast Enhance
Merck & Co. (MRK) posted better-than-expected third quarter earnings Thursday, whereas lifting its full-year revenue steering for a second time, thanks partly to spectacular gross sales of its blockbuster most cancers therapy…